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This review covers the literature published in 2003 for marine natural products, with 619 citations (413 for the period
January to December 2003) referring to compounds isolated from marine microorganisms and phytoplankton, green
algae, brown algae, red algae, sponges, coelenterates, bryozoans, molluscs, tunicates and echinoderms. The emphasis
is on new compounds (656 for 2003), together with their relevant biological activities, source organisms and country
of origin. Biosynthetic studies or syntheses that lead to the revision of structures or stereochemistries have been
included (78), including any first total syntheses of a marine natural product.
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1 Introduction
This review is of the literature for 2003 and describes 656 new
compounds from 243 articles. These numbers are comparable
to those of the past few years. We show structures only for
new compounds, or for previously reported compounds where
there has been a structural revision or a newly established
stereochemistry. Previously reported compounds for which first
syntheses or new bioactivities are described, are referenced, but
separate structures are generally not shown.
2 Reviews
A number of reviews have dealt with classes of com-
pounds: “Sterols in microorganisms”,1 “Bioactive macrolides
and polyketides from marine dinoflagellates”,2 “Chemistry
and biology of new marine alkaloids from the indole and
annelated indole series”,3 “Brominated diterpenes of marine
origin”,4 “Sulfur-containing natural products from marine
invertebrates”,5 “The cerebrosides”,6 “Nonribosomal peptides
from marine sponges”,7 “Bioactive polyhydroxysterols and
their sapogenins frommarine organisms”,8 “Sphingolipids from
marine organisms”,9 “A review of research on the cyanotoxin
cylindrospermopsin”,10 and “The manzamine alkaloids”.11
Reviews that focus on bioactivity and development as drug
candidates include: “Natural products as sources of new drugs
over the period 1981–2002”,12 “Marine natural products as
prototype agrochemical agents”,13 “Detection of pharmacolog-
ically active natural products using ecology”,14 “Marine phar-
macology in 2000: antitumour and cytotoxic compounds”,15
“Bioactive natural products frommarine invertebrates and asso-
ciated fungi”,16 “Marine pyridoacridine alkaloids and synthetic
analogues as antitumour agents”,17 “Drugs from the deep:
marine natural products as drug candidates”,18 “Marine-derived
anticancer agents in clinical trials”,19 “Marine natural products
as lead anti-HIV agents”,20 “Natural products with anti-HIV
activity from marine organisms”,21 “Algae, a possible source for
new drugs in the treatment of HIV and other viral diseases”,22
and “Antimycobacterial natural products”.23
Chemical synthesis is the theme of a number of reviews
covering specific types of compounds through to more generally
applicablemethodology: “Total synthesis of (+)-macrosphelides
A, C, E, F and G based on enzymatic function”,24 “The
total syntheses of phorboxazoles-new classes in natural product
synthesis”,25 “The development of a practical total synthe-
sis of discodermolide”,26 “Synthesis of the pyrrole-imidazole
alkaloids”,27 “Chemistry of bis-spiroacetal systems: natural
products, synthesis and stereochemistry”,28 “Approaches to-
wards the synthesis of cephalostatins, ritterazines and saponins
from Ornithogalum saundersiae”,29 “New and old challenges in
total synthesis. From concept to practise”30 and “Microtubule-
stabilizing marine metabolite laulimalide and its derivatives:
synthetic approaches and antitumour activity”.31
Other more general reviews include: “Molecular biodiversity.
Case study: Porifera (sponges)”,32 “Microalgal metabolites”,33
“Enhancing marine natural product structural diversity and
bioactivity through semisynthesis and biocatalysis”,34 and “Ma-
rine natural products”.35 References to other reviews are more
appropriately placed in the following sections. The Marinlit
database36 continues to be updated and has again been used
as the basis for the preparation of this present review.
3 Marine microorganisms and phytoplankton
Probably the most important paper on marine microorganisms
in 2003 was the first report on chemistry from the new obligate
marine actinomycete taxon Salinospora.37 In excess of 2 500
strains from this taxon have now been isolated and the potent
proteasome inhibitor salinosporamide A 1 was isolated from
a culture of a Salinospora sp. originating from a heat-treated
marine sediment sample from the Bahamas. The structure of
salinosporamide A, including the absolute stereochemistry, was
deduced through spectral and X-ray analyses. Salinosporamide
A displayed potent and selective in vitro cytotoxicity against
cell lines in the NCI panel. Salinosporamide A also exhibited
highly potent inhibition of the proteasomal chymotrypsin-like
proteolytic activity of purified 20S proteasome. The unique
functionalisation of the core-fused c-lactam-b-lactone bicyclic
ring structure of salinosporamide A 1 appears to contribute to
its potency. The thiazolyl peptide antibiotics, nocathiacins I–III
2–4, have been isolated from the culture broth of Nocardia sp.
(source not given).38 The nocathiacins exhibit potent in vitro
activity against a wide range of bacteria, including several
multiple-drug resistant pathogens and also exhibit excellent
in vivo efficacy in a systemic Staphylococcus aureus infection
mouse model.39 However, nocathiacin I 2 was found to be
identical to an antibiotic isolated from Amycolatopsis sp.40 but
spectral data and stereochemical details had not been originally
reported for this compound. Two cyclic thiopeptides 5 and
6, obtained from a culture of Bacillus cereus isolated from
the marine sponge Halichondria japonica,41 exhibited potent
antibacterial activities against Staphylococci and Enterococci
1 6 N a t . P r o d . R e p . , 2 0 0 5 , 2 2 , 1 5 – 6 1
Pu
bl
ish
ed
 o
n 
19
 Ja
nu
ar
y 
20
05
. D
ow
nl
oa
de
d 
on
 1
4/
11
/2
01
3 
03
:3
0:
23
. 
View Article Online
sp., and were active against multiple-drug resistant strains.42
(6Z)-Geometry for these compounds was implied by ROESY
correlations. 1H-15N HMBC analysis was used in determining
the structure of bacillamide 7, a peptidic metabolite of an
algicidal marine Bacillus sp. isolated during the termination of
a bloom of Cochlodinium polykrikoides in Masan Bay, Korea.43
Bacillamide was shown to be active against a wide range of
dinoflagellates and raphidophytes.44 Culture of an exocellular
extract of a Pseudomonas sp. associated with Ircinia muscarum
from the Bay of Naples, Italy gave the cyclotetrapeptide 8.45
The amino acid stereochemistry was established by standard
methods (for example, chiral HPLC analysis of the acid
hydrolysate, Marfey’s method etc.). Four Streptomyces sp. of
diverse origin yielded a range of metabolites. Firstly, culture of
a Streptomyces sp. from a sediment sample from Oahu, Hawaii,
yielded the antibacterial and antifungal metabolite bonactin
9.46 Parimycin 10, a new 1,4-anthraquinone, was isolated from
a Streptomycete sediment sample from Laguna de Terminos,
Gulf of Mexico. Parimycin had moderate activity against B.
subtilis, Streptomyces viridochromogenes, S. aureus and E. coli,
in addition to activity against a number of human tumour
cell lines.47 A Streptomyces sp. cultured from an unidentified
Mexican marine invertebrate yielded the cytotoxic indoles 11–
13 which had moderate activity against a panel of 14 tumour
cell lines.48 Finally, the anthracycline komodoquinone A 14
and the aglycone komodoquinone B 15 were isolated from a
culture of a Streptomyces sp. isolated from marine sediment
off Komodo Island, Indonesia. Komodoquinone A displayed
dose-dependent neuritogenic activity against the neuroblastoma
cell line Neuro 2A.49 A culture broth of an ATCC strain of
the marine gliding bacterium Saprospira grandis yielded four
neoverrucosane diterpenoids, 16–19. The relative and absolute
stereochemistries of 16 were determined by standard methods50
(for example, X-ray analysis, NOESY andROESYNMR exper-
iments, themodifiedMoshermethod, chiral HPLC, comparison
of circular dichroism (CD) or other optical data against stan-
dards or model compounds etc.). The marine myxobacterium
Haliangium ochraceum,51 originally H. luteum, yielded several
new isomers of the polyene antifungal antibiotic haliangicin.52,53
These are cis-haliangicin 20 and haliangicins B–D 21–23,
geometrical isomers of the polyene and epoxide moieties. The
stereochemistry of the epoxide in the known haliangicin 2453
has been determined as trans. All of the haliangicins were active
against the phytopathogenic fungusPhytophthora capsici.54 Two
siderophores, pseudoalterobactins A 25 and B 26, were isolated
from a culture of the bacterium Pseudoalteromonas sp. isolated
from the marine sponge Cinachyrella australiensis collected
in Palau. Both compounds displayed strong binding affinity
for the ferric ion in the chrome azurol S (CAS) assay.55 The
bactericidal compound 27, obtained from a culture of a new
marine species Pseudoalteromonas phenolica sp. nov., isolated
from seawater collected off Ogasawara Island Japan,56 had
potent activity against methicillin-resistant S. aureus (MRSA)
and was also strongly active against Enterococcus serolicida,
E. faecium and E. faecalis.57 This compound is available
commercially, but this is the first reported isolation as a natural
product. Cultures of two marine bacterial strains isolated from
cultures of Pecten maximus larvae in Galicia, Spain, led to
the first reported isolation, as natural products, of a series
of DD-diketopiperazines 28–31 and established them as potent
inhibitors of the pathogenic marine bacterium Vibrio anguil-
larum. The structures were confirmed by synthesis.58 A cytotoxic
polycyclic xanthone 32 has been isolated from the culture broth
of the actinomycete Actinomadura sp.59 The phenoxazin-3-one
antibiotics, chandrananimycins A–C 33–35, were also isolated
from a culture of Actinomadura sp. derived from sediment from
Jiaozhou Bay, China. Chandrananimycins A–C were active
against human tumour cell lines while 35 exhibited potent
activity against the fungus Mucor meihei and the bacteria B.
subtilis and E. coli, and antialgal activity against the microalga,
Chlorella vulgaris, C. sorokiniana and Scenedesmus suspicatus.60
The fungus Aspergillus tamarii was isolated from driftwood
collected inOkinawaand cultured to yield a pentacyclic oxindole
alkaloid, speradine A 36. The structure and relative stereo-
chemistry of 36 were confirmed by X-ray analysis. Speradine
A exhibited inhibitory activity against histone deacetylase and
antibacterial activity against Micrococcus luteus.61 A culture of
the fungus Aspergillus ostianus, isolated from an unidentified
marine sponge fromPohnpei, was the source of three chlorinated
antibiotics, the asperlactone derivatives 37 and 38 and the
aspyrone derivative 39. Compound 37 was the most potent,
inhibiting the growth of themarine bacteriumRuegeria atlantica
and that of E. coli and S. aureus to a lesser extent.62 Five novel
depsipeptides, aspergillicins A–E 40–44, were obtained from a
culture of Aspergillus carneus collected from estuarine sediment
in Tasmania, Australia. The amino acid sequences were assigned
byMSn ion-trapESImass spectrometry and stereochemistrywas
assigned by standard methodology. The aspergillicins exhibited
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modest cytotoxicity against Haemonchus contortus.63 A chiral
dipyrrolobenzoquinone derivative, terreusinone 45, has been
obtained from a cultured strain of the marine algicolous fungus
Aspergillus terreus isolated from the surface of the marine
red alga Halymenia acuminata collected from Bijin Island,
South Korea. The absolute stereochemistry was determined by
a combination of Horeau’s method and quantum chemistry
calculations. Terreusinone has intense UV-A absorbtivity.64 A
culture of Penicillium brocae from the tissue of the Fijian sponge
Zyzzya sp. was the source of three novel cytotoxic polyketides,
brocaenols A–C 46–48. These contain the unusual enolised
oxepine lactone ring system. Structure determination included
an INADEQUATE experiment on brocaenol A. The absolute
stereochemistry of 46 was established by a standard method
and extended to 47 and 48 by comparison of CD and optical
rotation data.65 Brocaenols A–C displayed moderate activity
against the HCT-116 cell line. Structures for brocaenols B and
C were reversed in the original paper, but a correction has since
been published.66 The steroids isocyclocitrinol A 49 and 22-
acetylisocyclocitrinol A 50 were extracted from a salt water
culture of Penicillium citrinum isolated from an Axinella sp.
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collected in Papua New Guinea.67 The absolute stereochemistry
of 50 was established by standard methods, extended to 49,
leading to the structural revision of cyclocitrinol, previously
isolated froma terrestrialP. citrinum,68 to 51. Compounds 49 and
50 displayed weak antibacterial activity against Staphylococcus
epidermidis and Enterococcus durans. The halovirs A–E 52–56,
lipophilic linear peptides, are potent in vitro inhibitors ofHerpes
simplex viruses 1 and 2 and were isolated from a Scytalidium
sp. sourced from the Caribbean seagrass Halodule wrightii.69
Two cyclic heptapeptides, scytalidamides A 57 and B 58, have
been isolated from the culture broth of another Scytalidium
sp. derived from the surface of the green alga Halimeda sp.
collected off the Bahamas. The absolute configurations were
confirmed by standard methods including CD measurements.
Both scytalidamides displayed moderate cytotoxicity to the
HCT-116 cell line in vitro.70 Trichodermamides A 59 and B 60,
modified dipeptides, were isolated from cultures of Trichoderma
virens isolated from the ascidian Didemnum molle and from the
surface of a green alga of the genus Halimeda, both collected
in Papua New Guinea. The ascidian-derived culture contained
trichodermamide A with traces of trichodermamide B while a
greater quantity of trichodermamide B was isolated from the
algal-derived strain. The structure of 59 was assigned by X-
ray diffraction while the absolute stereochemistry was deter-
mined using the modified Mosher method. Trichodermamide B
displayed significant in vitro cytotoxicity against HCT-116 and
moderate antimicrobial activity against amphoterocin-resistant
C. albicans, MRSA and vancomycin-resistant E. faecium.71
Trichodermamide A is closely related to penicillazine, reported
from a marine-derived Penicillium sp.72 The reported structures
differ only in the translocation of ester and amide bonds,
but spectral data comparison suggests that these compounds
may be identical. Two macrolides, modiolides A 61 and B
62, and a linear pentaketide modiolin 63 have been isolated
from the culture of Paraphaeosphaeria sp. separated from the
marine horsemusselModiolus auriculatus, collected inOkinawa.
The absolute stereochemistry of 61 was determined by the
exciton chirality method73 using a p-methoxycinnamoyl ester,
while the absolute stereochemistry of 63 was defined by the
modifiedMoshermethod.ModiolidesAandB exhibitedmodest
antibacterial activity againstMicrococcus luteus andNeurospora
crassa.74 A culture of the marine fungus Wardomyces anomalus,
isolated from the green alga Enteromorpha sp. collected in the
Baltic Sea, yielded two xanthone derivatives, anomalins A 64
and B 65.75 The anomalins were only weakly antimicrobial, but
anomalin A possessed significant tyrosine kinase p56lck enzyme
inhibitor activity and antioxidative properties. Remisporine A
66, a novel cyclopentachromenone, isolated from a culture of the
marine fungus Remispora maritima from an unspecified wood
source, is unstable under normal conditions and autocatalyti-
cally dimerises stereospecifically, via a Diels–Alder reaction, to
remosporine B.76 A new anthraquinone, evariquinone 67, and
the new prenylxanthone isoemericellin 68 were isolated from
a culture of the fungus Emericella variecolor derived from the
marine sponge Haliclona valliculata collected at Elba, Italy. The
known C-glycosidic depside stromemycin 6977 was also isolated,
and the previously undescribed double bond configurations
established. Evariquinone 67 showed antiproliferative activity
towards KB and NCI-H460 cells.78 A culture of a marine
strain of the fungus Epicoccum purpurascens, isolated from
inner tissue of the jellyfish Aurelia aurita collected from the
North Sea, Germany, yielded the tetramic acid derivative
epicoccamide 70. Attempts to resolve the stereochemistry at
C-4 and C-8 by comparision of CD spectra with those of
similar compounds were ambiguous.79 Two highly oxygenated
polyketides, phomoxin 71 and phomoxide 72, are metabolites
from a Phoma sp. isolated from a microbial mat collected
from a Bahaman hypersaline pond, along with eupenoxide 73,
a previously synthesised, but unpublished fungal metabolite.80
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An actinomycete, Pseudonocardia sp., isolated from littoral
sediment from Mauritius, Indian Ocean, was the source of
a new phenazine derivative, phenazostatin D 74 which is
the meso- form of the known antibiotic phenazostatin B.81,82
Investigations of a collection of Lyngbya majuscula from Puerto
Rico resulted in the isolation of three new metabolites, a
quinoline alkaloid, 75, malyngamide T 76 and a tryptophan
derivative 77.83 Geometries for the vinyl chloride functionalities
of 75 and 76were established as (E) by 1H-13C coupling constant
measurement from HSQMBC NMR experiments.84 Six cyclic
depsipeptides, guineamides A–F 78–83, were isolated from a
collection of Lyngbya majuscula collected from Papua New
Guinea. Absolute stereochemistries for most of the amino acids
were determined by standard methods. Guineamides B and
C were moderately cytotoxic to a mouse neuroblastoma cell
line.85 L. majuscula from Papua New Guinea was the source of
the novel cyclic dodecapeptide wewakazole 84 which contains
an unprecedented number of five-membered heterocyclic rings
(six). Due to extensive signal overlap the structural assignment
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requiredmultiple NMRandMS/MS experiments. The absolute
stereochemistry was determined by standard methods.86 L.
majuscula from the southern Kenyan Coast was the source
of the cyclic depsipeptide homodolastatin 16 85. The absolute
stereochemistries of most of the amino acids in homodolastatin
16 were determined by standard methods. Homodolastatin
16 85 displayed moderate activity against oesophageal and
cervical cancer cell lines.87 The cyclic peptide lyngbyastatin 3
86, isolated from L. majuscula collected from Guam, contains
two unusual amino acid units, including 4-amino-2,2-dimethyl-
3-oxopentanoic acid (Ibu). The configuration of the Ibu unit was
established by acid hydrolysis and comparison with synthetic
standards, while the absolute stereochemistries of the remaining
residueswere determinedby standardmethods.Lyngbyastatin 3,
along with the previously isolated lyngbyastatin 1 and dolastatin
12,88 are in fact diastereotopic mixtures of both Ibu epimers.
Lyngbyastatin 3 86 exhibited activity against KB and LoVo cell
lines in vitro, but was poorly tolerated in vivo with little anti-
tumour activity.89 Three new malyngamides, U–W 87–89, have
been isolated fromL. majuscula collected in PapuaNewGuinea.
Partial relative stereochemistries only were determined.90 A
collection of Lyngbya sp. from Palau yielded ulongapeptin 90,
a cytotoxic cyclic depsipeptide,91 while a Lyngbya sp. from
Guam yielded two new compounds, 15-norlyngbyapeptin A
91 and lyngbyabellin D 92.92 The absolute stereochemistries
in each case were determined through degradative studies
and/or comparison with commercially available and synthetic
standards. Ulongapeptin was moderately cytotoxic against KB
cells in vitro91 and lyngbyabellin D displayed activity against
the KB cell line.92 Bioassay-guided fractionation of an extract
from a Lyngbya sp. collected in Palau led to the isolation of
palau’amide 93. Effective use was made of a band-selective
HMBC experiment to unambiguously assign 13C NMR sig-
nals that were separated by only 0.1 ppm.93 Except for C-
37, relative and absolute configurations were determined by
standard methods. By modelling, and from NOE data, C-37
was assigned as having the (S) configuration. Palau’amide 93
exhibited potent cytotoxicity againstKB cells.94 Semiplenamides
A–G 94–100, anandamide-like fatty acid amides, were isolated
from a collection of Lyngbya semiplena collected in Papua New
Guinea. The absolute stereochemistries of the amino alcohols
in semiplenamides C–E 96–98 were elucidated as all L by
chemical derivatisation and chiral GCMS methods. All of the
semiplenamides displayed toxicity in the brine shrimp assay,
while semiplenamides A, B and G exhibited weak affinity for
the rat cannabinoid CB1 receptor. Semiplenamide A was also a
moderate inhibitor of the anandamide membrane transporter
(AMT).95 Samples of the marine cyanobacterium Symploca
sp. collected in Palau were the source of the depsipeptides
tasipeptins A 101 and B 102,96 and a cytotoxic peptide,
tasiamide B 103.97 The relative and absolute configurations of
the tasipeptins and tasiamide B were determined by standard
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methods except for the configurationofC-28 in tasiamideB.This
was tentatively suggested as (S) fromNMRdata analysis.97 Both
tasipeptins exhibited moderate cytotoxicity towards KB cells in
vitro. Also collected in Palau was an assemblage of a Symploca
sp. cyanobacterium and an unidentified red alga. From this was
isolated the iodinated diterpenes, tasihalides A 104 and B 105.
These compounds possess a novel cage structure with both an
oxabicyclic ring system and a cis-decalin system. These are the
only examples of iodinatedditerpenes in nature. Since terpenoids
are almost never reported from marine cyanobacteria, but
halogenated terpenes are ubiquitous in red algae, the authors
speculate that the more likely source of the tasihalides is the alga
and not the cyanobacterium.98 Two polyunsaturatedmonocyclic
triterpenes 106 and 107 have been isolated from a culture of
the common marine diatomRhizosolenia setigera. The structure
of a related monocyclic sesterterpene 108 was also proposed
on the basis of mass spectral comparisons with compounds
106 and 107.99 Amphidinolide X 109100 and amphidinolide Y
110101 are cytotoxic 16- and 17-memberedmacrodiolides isolated
from cultures of the marine dinoflagellate Amphidinium sp.,
originally separated from the inside cells of the marine acoel
flatworm Amphiscolops sp. collected from Okinawa. Amphidi-
nolide Y exists as a 9 : 1 equilibrium mixture of the 6-keto-
110 and 6(9)-hemiacetal 111 forms. Both amphidinolides X
and Y were moderately cytotoxic against murine lymphoma
L1210 and human epidermoid carcinoma KB cells in vitro.
Feeding experiments with 13C-labelled acetates suggested that
amphidinolide Y might be a precursor of amphidinolide X.101 A
culture of the dinoflagellate Symbiodinium sp., a symbiont of the
soft coralClavularia viridis collected from Okinawa, yielded two
diastereoisomeric norcarotenoids 112 and 113. Both compounds
exhibited moderate growth-inhibitory activity in vitro against
a range of human cancer cell lines.102 A culture of the free-
living marine dinoflagellate Symbiodinium sp. isolated from a
tide pool, Coconut Island, Hawaii,103 yielded the polyhydroxy
compound zooxanthellamideA 114.104 Cultures of a strain of the
dinoflagellateProrocentrum lima105 affordedokadaic acidmethyl
ester 115, norokadanone 116 and an okadaic acid diol ester
117.106 Three hydroxybenzoate saxitoxin analogues, GC1–GC3
118–120, have been isolated from the cultured dinoflagellate
Gymnodinium catenatum originally isolated from a planktonic
bloom in Tasmania. GC1 and GC2 are the epimeric 11-
hydroxysulfate derivatives of GC3, the 4-hydroxybenzoate ester
derivative of decarbamoylsaxitoxin. Preliminary investigations
indicate that the compounds bind to rat brain sodium channels,
in keeping with known PSP toxins.107 Biosynthetic investi-
gations using 13C-labelled precursors of the meroterpenoid
neomarinone, originally isolated from culture of an unidentified
marine actinomycete from sediment from Batiquitos Lagoon,
California,108 led to the structural revision of neomarinone to
121.109 A correction to the text of the article describing the struc-
ture and absolute stereochemistry of phormidolide from the
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marine cyanobacterium Phormidium sp.110 has been published,
amending two descriptors [(17R,26R) to (17S,26S)].111 The
absolute configuration of the fungal metabolite phomopsidin
122, derived from a cultured strain of Phomopsis sp.,112 has
been determined by the exciton chirality method. Phomopsidin
exhibited potent anti-microtubule activity in a microtubule
assembly assay utilising purified porcine brain microtubule
proteins.113 A total synthesis of petrobactin, a siderophore
isolated from the marine bacterium Marinobacter hydrocarbon-
oclasticus has been completed. Comparison of the 1H NMR
spectrum of the synthetic product with literature data for the
natural product114 resulted in a structural revision of petrobactin
from 2,3-dihydroxybenzoyl- to 3,4-dihydroxybenzoyl-moieties.
This 3,4-dihydroxybenzoyl analogue 123 was also synthesised,
giving 1H and 13C NMR spectra that were consistent with
those of the natural product.115 The first total synthesis of
yanucamide A 124, which was isolated from an assemblage of
L. majuscula and a Schizothrix species,116 has been achieved via
amide and ester coupling methods. The synthesis established the
configuration at C-3, originally unassigned due to ambiguity,
and revised the configuration at C-22.117 In synthetic studies
towards congeners of phomactin A, total syntheses of structures
isomeric to that proposed for the phomactin known as Sch
49028, also isolated from the marine fungus Phoma sp.,118 are
described. None of the isomers showed spectral data consistent
with those of the natural product so it is proposed that Sch
49028 does not exist and that the NMR spectral data should
have been assigned as phomactin A.119 Other first total syntheses
reported include that of (±)-spiroxin C, originally isolated from
culture of an unidentified fungal strain from a soft coral from
Vancouver Island, Canada.120 This involved a Suzuki–Miyaura
cross-coupling reaction.121 Apratoxin A, a cyclodepsipeptide
from Lyngbya sp. collected in both Guam122 and Palau,123 has
been synthesised.124 The relative and absolute stereochemistries
of amphidinoketide I 125, originally isolated from the dinoflag-
ellate Amphidinium sp. collected in the Virgin Islands,125 have
been determined by total synthesis of all four diastereoisomers.
Molecular modelling was used to infer that the natural product
is not the thermodynamically preferred diastereoisomer.126 Two
syntheses of the 19-membered macrolide (+)-amphidinolide
T1127,128 have been achieved,129,130 along with the synthesis130 of
amphidinolides T3131 and T5.128 Synthesis of the structurally
complex gymnocin-A, a polyether toxin with 14 contiguous
rings, from the red tide dinoflagellate Karenia mikimotoi,132
has been accomplished through the use of B-alkyl Suzuki–
Miyaura coupling-based methodology.133 Following the first
total synthesis of gambierol, a marine polycyclic ether toxin
originally isolated from the marine dinoflagellate Gambierdiscus
toxicus,134 preliminary structure–activity relationship studies
suggest that functionalities in the H ring and unsaturated
sidechain are essential for potent murine toxicity.135 A compet-
itive inhibition assay using the isotopically labelled brevetoxin
dihydroBTX-B ([3H]PbTx-3), demonstrated that gambierol134,136
and gambieric acid-A137,138 from the dinoflagellateGambierdiscus
toxicus inhibit the binding of brevetoxins to site 5 of the voltage-
gated sodium channel of excitable membranes,139 while effects
of brevetoxins produced by the dinoflagellate Karenia brevis
(formerly Ptychodiscus breve and Gymnodinium breve)140 on the
murine myeloma cell line SP2/O, a possible model for in vitro
studies for immune cells, suggest that the brevetoxins have an
aberrant effect on cell division.141
4 Green algae
As in 2002, very few new compounds have been reported from
green algae. The cyclic depsipeptide kahalalide F 126, originally
isolated from both the mollusc Elysia rufescens and from the
dietary source, the green alga Bryopsis sp.,142 was introduced
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into Phase I trials by Pharma Mar SA as a lead compound
against prostate cancer. The structure of kahalalide F has been
corrected based on a series of degradation reactions. The planar
structure only was originally defined and the stereochemistry
subsequently assigned.143 The degradation results indicate that
the correct structure is a stereoisomer 126, in which the original
assignments for Val-3 and Val-4 have been reversed. This
stereochemistry is crucial for the observed bioactivity.144 Twelve
new terpene esters, 127–138 have been isolated from the green
alga Caulerpa prolifera collected from Saronicos Gulf, Greece.
TheC. prolifera extract exhibitedmoderate to significant activity
against three unidentified strains of marine bacteria, in addition
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to strong growth inhibitory effects on the fouling microalga
Phaeodactylum tricornutum.145 The first total synthesis of (±)-
dihydrorhipocephalin, a bioactive sesquiterpene isolated from
Caribbean marine green algae of the genera Penicillus and
Udotea,146 has been reported.147
5 Brown algae
A wider range of compounds has been reported from brown
algae in 2003 than in 2002, when terpenes and steroids were
the predominantly reported compound classes. Six tetraprenyl-
toluquinols 139–144, two triprenyltoluquinols 145 and 146 and
two tetraprenyltoluquinones 147 and 148 were isolated from
the brown alga Cystoseira crinita collected from the south
coast of Sardinia. All compounds were tested for antioxidative
properties in the a,a-diphenyl-b-picrylhydrazyl radical (DPPH)
and thiobarbituric acid reactive substances (TBARS) assay sys-
tems. Compounds 139–146 exhibited potent radical-scavenging
effects while 147 and 148 were significantly less active, but still
comparable to that of butylated hydroxytoluene (BHT). The
radical scavenging activity of compounds 142, 144 and 148 was
further assessed using theTrolox equivalent antioxidant capacity
(TEAC) and photochemiluminescence (PCL) assays that con-
firmed the potent radical scavenging ability. Compounds 139
and 140 were moderately cytotoxic against several carcinoma
cell lines.148 Four hydroazulene diterpenes, dictyone acetate 149,
dictyol F monoacetate 150, isodictytriol monoacetate 151 and
cystoseirol monoacetate 152, were isolated from the brown
alga Cystoseira myrica collected in the Gulf of Suez. All four
compounds exhibited moderate cytotoxicity against the murine
cancer cell line KA3IT, but reduced cytotoxicity against normal
NIH3T3 cells.149 Dictyone acetate along with a pachydictyol A
derivative 153 (incorrect structures shown in original reference)
were also isolated from the brown alga Dictyota dichotoma
collected from the Red Sea.150 D. dichotoma from the Arabian
Sea was the source of two seco-dolastanes dichotone 154 and
dichotodione 155,151 two dolastane diterpenoids, dichototetraol
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156 and dichopentaol 157,152 and the related dichotenones
A 158 and B 159, two enone dolastane diterpenoids.153 The
configurations of 154 and 155 were determined by comparison
of spectral data against those of known compounds. The
new diterpene dictyocrenulol 160 was isolated from the brown
alga Dictyota crenulata collected from Easter Island.154 Eisenia
bicyclis collected at Johgashima Island, Japan, was the source
of nine novel oxylipin compounds 161–169.155 Five of these,
eiseniachlorides A–C 161–163 and eiseniaiodides A 164 and B
165, are ecklonialactone derivatives and two more, 166 and 167,
are cymathere type oxylipins. Stereochemistries of compounds
161–165 and 169 were elucidated by NMR analyses, but the
relative stereochemistry at C-9 in 168 could not be determined
unambiguously. Olefin geometry in 166 was ambiguous, but
considered to be (Z) on biosynthetic grounds, and at least one
olefin in compound 167 was (Z). A 22-membered cyclic lactone,
lobophorolide 170, was isolated from the common brown
alga Lobophora variegata, collected at several reef locations
in the Bahamas and from the Red Sea. The structure was
elucidated by spectral data analysis and comparison against
data published for tolytoxin156 and swinholide A.157,158 It is
proposed that lobophorolide and tolytoxin share the same
relative configuration at all stereogenic centres in the macrolide
portion of the molecule, while a (6R) configuration is suggested
for both compounds rather than the (6S) configuration pro-
posed previously for tolytoxin.156 The absolute configuration of
lobophorolide is proposed to be the same as that of tolytoxin
based on optical rotation. Lobophorolide 170 displayed potent
and highly specific activity against the marine filamentous fungi
Dendryphiella salina and Lindra thalassiae in addition to potent
activity against C. albicans and antineoplastic activity against
the HCT-116 cell line.159 The brown alga Sargassum asperfolium,
collected in the Suez Gulf, was the source of the steroidal
metabolite saringosterone 171,160 while a novel steroid 172 has
been isolated from the brown alga S. carpophyllum from the
South China Sea.161 Ecklonia stolonifera collected from S. Korea
yielded a new phlorotannin, eckstolonol 173, which possessed
potent DPPH radical scavenging activity.162 Dolabellane 1,
originally isolated from the opistobranch mollusc Dolabella
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californica,163 has been characterised as the major secondary
metabolite and active chemical defense agent against herbivores
(sea urchins and fish) in the brown alga Dictyota pfaffi.164 (±)-
Hedaol B, a bisnorditerpene isolated from the Japanese brown
alga Sargassum sp.,165 has been synthesised with geranyl acetone
as a starting material and alkylation of silyl cyanide as the key
step in the synthesis.166
6 Red algae
The genus Laurencia continues to be a prolific source of new
metabolites. A brominated bisabolene derivative, aldingenin A
174, was isolated from Laurencia aldingensis collected from
Brazil. Biogenetic considerations were of value in the struc-
tural assignment.167 From L. microcladia from Elba Island, a
calenzanane sesquiterpene, debromoisocalenzanol 175 and an
indene-type sesquiterpene 176 were isolated,168 while four new
sesquiterpenes, 177–180 including the snyderol derivatives 179
and 180, have been isolated from L. obtusa collected from
Bademli, Turkey. Compound 179 was active against D6 and
W2 clones of the malaria parasite Plasmodium falciparum.169
Laurencia perforata, collected from the Great Barrier Reef,
Australia, was the source of the sesquiterpenes 4-hydroxy-1,8-
epi-isotenerone 181 and two 3-epi-perforenone A derivatives,
182 and 183.170 A collection of L. obtusa from Greece yielded
four new brominated diterpenes,171 prevezols C–E 184–186, and
neorogioldiol B 187, together with the known prevezol B 188,
whose structure has been revised from that reported originally.172
Prevezol B and neorogioldiol displayed significant cytotoxicity
against the human tumour cell lines MCF7, PC3, HeLa,
A431 and K562 while prevezol C only exhibited significant
cytotoxicity against HeLa and A431 cell lines. Prevezol D
was moderately active against all cell lines.171 Two labdane
type brominated diterpenes 189 and 190 have been isolated
from L. obtusa from Greece. These structures contain unprece-
dented eight- and seven-membered ether rings respectively.173
Six new bromophenols, 191–196 were isolated from Rhodomela
confervoides collected from the coast of Qingdao, China.174
Compounds 193 and 195 may be artifacts of the extraction
and isolation processes.174 Compounds 194 and 195 were also
reported in another paper by the same authors, along with
the isolation of the known 3-bromo-4,5-dihydroxybenzoic acid
methyl ester (but new as a natural product) from the same
source (R. confervoides).175 This benzoyl ester has previously
been synthesised176 but the spectral data were not reported.
R. confervoides from Qingdao was also the source of bro-
mophenols, 197 and 198. The phenol 198, which might also be
derived from 197 during isolation,177 exhibitedmoderate activity
against five strains of bacteria.178 Five monoterpenes 199–203
of the ochtodane class have been isolated from the red alga
Portieria hornemanni (source not given).179 Themarine polyether
triterpenoid dehydrothyrsiferol, originally isolated from the red
alga Laurencia pinnatifida,180 was shown to induce apoptosis
in estrogen-dependent and independent breast cancer cells.181
Elatol, a halogenated sesquiterpene alcohol from the red alga L.
elata182 inhibited six species of human pathogenic bacteria, with
significant antibacterial activities against Staphylococcus epi-
dermis, Klebsiella pneumonia and Salmonella sp.183 Iso-obtusol
from the red alga Laurencia obtusa184,185 exhibited antibacterial
activity against four bacterial species with significant activity
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against K. pneumonia and Salmonella sp. Further tests indicated
that both compounds were bacteriostatic rather than bacte-
riocidal against the bacteria tested.183 Glutathione transferase
specific activity in Katharina tunicata (black chiton) was shown
to be affected by the brominated phenol lanosol,186 which is
prevalent among filamentous red algae of the Rhodomelaceae,
and frequently consumed byK. tunicata.187 The first asymmetric
total syntheses of (+)-3-(E)- and (+)-3-(Z)-pinnatifidenyne,
originally isolated from Laurencia pinnatifida,188,189 have been
reported and utilise an “olefin geometry-dependent” inter-
nal alkylation to give excellent stereoselectivity.190 The seven-
membered ring ether (+)-neoisoprelaurefucin 204, originally
isolated fromL. nipponica,191 has also been synthesised, allowing
the assignment of the absolute stereochemistry of the natural
product.192 A nickel-catalysed coupling reaction of an alkynyl
enone and an alkenylzirconium were the key steps in the
synthesis of isodomoic acid G 205, originally isolated from the
red alga Chondria armata from Kyushu Island.193 The sidechain
stereochemistry was established as (5′R) by comparison of CD
spectra of the natural and synthetic products.194
7 Sponges
Sponges continue to be an important source of novel secondary
metabolites and a notable growing trend is the characterisation
of compounds from bacteria and fungi that have been isolated
from sponges. Such compounds have been included in Section
3 of this review. There has also been increased interest in
fatty acid derivatives, many of which have biological activities.
An unusual galactofuranosylceramide, ectyoceramide 206, was
isolated from the Bahaman sponge Ectyoplasia ferox,195 while
a Jaspis species collected in Vanuatu was found to contain the
cytotoxic sphingosine derivatives jaspines A 207 and B 208.196
The Korean sponge Erylus nobilus was the source of the taurine
derivative 209.197 Another Korean sponge, a Stelletta species,
has yielded two cytotoxic compounds, glycerol ether 210198 and
cyclitol derivative norsarcotride A 211.199 Plakevulin A 212,
found to inhibitDNApolymerases aand c, was isolated from the
Okinawan spongePlakortis sp.200 Latrunculia corticata, collected
in the Gulf of Aqaba, Israel, was found to contain decalactone
glycosides latrunculinoside A 213 and B 214, which have anti-
feedant activity against goldfish.201 An inhibitor of membrane
type 1 matrix metalloproteinase (MT1-MMP), callysponginol
sulfate A 215, was isolated from Callyspongia truncata collected
in Japan.202 An undescribed Korean species of Stelletta was
found to contain cytotoxic acetylenic acids: stellettic acid A
216, (Z)- and (E)-stellettic acid B 217 and 218, and stellettic
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acid C 219 that exhibited marginal to moderate toxicity to five
human tumour cell lines.203 Interestingly, the same sponge also
yielded the glycerol derivatives of 217, the mildly cytotoxic 220
and 221 (inactive), along with other lysophosphatidylcholines
and monoglycerides 222–225.204 From a seemingly identical
Stelletta species, collected at a different Korean location, a
similar series of acetylenic acids was isolated including 216, a
dimeric anhydride 226 and a desmethoxy analogue 227; all were
mildly cytotoxic to human leukemia cells.205 The Indonesian
sponge Callyspongia pseudoreticulata yielded the diyne 228,
which was found to be toxic in the brine shrimp assay.206
A Diplastrella species, collected in the Philippines, yielded
a series of polyacetylenic diols, the diplynes A–E 229–233
and corresponding sulfates 234–236.207 Three new chlorinated
polyacetylenes 237–239 were isolated from the Californian
sponge Haliclona lunisimilis208 along with known compounds
originally isolated from theHaliclona’s nudibranch predator,Di-
aulula sandiegensis.209 The moderately cytotoxic polyacetylenic
amide, callyspongamide A 240, was obtained from Callyspon-
gia fistularis collected in the Red Sea.210 Three new amides,
241–243, along with the previously reported clathrynamide
A 244,211 were isolated from an Okinawan Psammoclemma
species. 212 The stereochemistry of 244 was determined (Mosher
method). All four compounds were found to be antifungal.
The absolute stereochemistry of the amino alcohol xestoaminol
C, originally isolated from a Fijian Xestospongia species,213
has been established as (2S,3R) by the synthesis of the N,O-
diacetyl derivative from (S)-alanine.214 A racemic synthesis
of 2-methoxy-13-methyltetradecanoic acid, isolated from a
Puerto Rican specimen of Amphimedon complanata,215 has
been reported.216 (R)-Strongylodiol B, originally isolated from
a Strongylophora species,217 was synthesised enantioselectively
using a Zn(II) acetylide addition to an aldehyde.218 Callyberynes
A and B, also known as callypentaynes, obtained from Japanese
specimens of Callyspongia truncata219 and Callyspongia sp.,220
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were synthesised using sequential Cadiot–Chodkiewicz cross-
coupling reactions.221 Erylus trisphaerus, collected in Dominica,
was found to contain the mildly cytotoxic polyketide lactone,
trisphaerolide A 245.222 A Madagascar specimen of Plakortis
aff. simplex yielded three cyclic peroxides, the plakortolides
H 246 and I 247 and andavadoic acid 248, all of which
were cytotoxic against a range of human tumour cell lines.223
The antimicrobial tetramic acid, melophlin C 249, from an
Indonesian specimen of Melophlus sarassinorum, was isolated
as an inseparable mixture of four stereoisomers arising from
the stereogenic centres at C-5 and C-10 (as evidenced by NMR
and modified Marfey’s method). A further twelve, less active
tetramic acids,melophlinsD–O 250–261, were also isolated from
the same sponge.224 Both plakortides M 262 and N 263, isolated
from a collection ofPlakortis halichondrioides fromPuertoRico,
exhibited potent cytotoxicity to an array of human tumour
cell lines.225 A Japanese specimen of Monotria japonica yielded
the monotriajaponides A–D 264–267 which can lyse starfish
oocytes without disruption of nuclear structure.226 Interestingly,
the absolute stereochemistries of 265–267, as determined by
reduction and a modified Mosher method, were opposite
to those determined for the plakortides 262 and 263. The
asymmetric synthesis of (+)-rottnestol, originally isolated from
a Haliclona species,227 using a Stille coupling firmly established
the absolute stereochemistry as (12R). Similarly, syntheses of
(+)-raspailol A and (+)-raspailol B, originally obtained from
a Raspailia species,228 have established a (12R) configuration
for these two metabolites also.229 An unusual bis-dimedone
thioether with strong UV A and B absorption, benzylthiocre-
llidone 268, was isolated from a Great Barrier Reef collection
of Crella spinulata; the structure was reported in 2002,230 but
was omitted from the 2002 review.231 Okadaic acid, originally
isolated fromHalichondria okadai,232 and subsequently found to
be a dinoflagelate and shellfish toxin,233,234 has been investigated
for potential as a defense molecule for the Adriatic sponge
Suberites domuncula. Use of an ELISA assay established that
okadaic acid was localised in the epithelium of the lacunae and
water channels of the sponge, as well as in bacteria located
in the sponge tissue. It was postulated that okadaic acid acts
as a stimulant of the sponge immune system to the presence
of bacteria, but in higher concentrations causes apoptosis.235
Two analogues of okadaic acid, 27-O-acetylokadaic acid 269
and 27-O-acetyldinophysistoxin 1 270, were isolated from a
British Columbian sponge Merrianum oxeato and found to
be potent G2 checkpoint inhibitors and highly cytotoxic.236
A Papua New Guinean sponge, Cymbastela sp., was found to
contain the cytotoxic peptide milnamide D 271 along with the
related peptides hemiasterlin237 and milnamide A.238 All three
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compounds were inhibitors of tubulin polymerisation.239 Three
unusual new cyclic peptides, the kapakahinesE–G 272–274, have
been isolated from a Micronesian collection of Cribrochalina
olemda and reported as cytotoxic to P388 murine leukemia
cells.240 The previously described sulfoxide, waiakeamide 275,
and a new sulfone analogue 276 were isolated from a Haliclona
sp. collected in Palau. The sulfone 276 was found to inhibit the
settlement of larvae of the blue mussel (Mytilus edulis gallo-
provincialis).241 The myriastramides A–C 277–279 were isolated
from the same Philippine collection of Myriastra clavosa that
had previously yielded the clavosidemacrolides.242,243 Leucamide
A, originally isolated from the Australian sponge Leucetta
microraphis,244 has been synthesised.245 Due to differences in
biological activity, the cis,cis- 280 and reputed trans,trans-
281 isomers of ceratospongamide, originally isolated from the
Indonesian symbiotic pairing of the red alga Ceratodictyon
spongiosum and the sponge Sigmadocia symbiotica,246 continue
to attract considerable attention from synthetic chemists. Al-
though both rotamers had been synthesised previously,247 slight
differences in the NMR spectra of the synthetic trans,trans
isomer 281 and the isolated natural product were noted.
Suspecting a possible epimerisation the trans,trans-[D-allo-Ile]
isomer, 282 was synthesised, by two separate routes, to produce
a compound that is identical in all respects to the natural
isomerisation product.248 Phakellistatins 1249 and 10,250 have
been synthesised.251 Phakellistatin 1 was found to exist as the
all-cis rotamer at the proline residues, while phakellistatin 10
was determined to be all-trans. Interestingly, both synthetic
products were more than 100-fold less cytotoxic than the
natural product.251 A large (500 kg) collection of a Phakellia
species from Chuuk, Micronesia, yielded the growth inhibitory
phakellistatin 12 283,252 while a Chinese collection of Phakellia
fusca yielded the very cytotoxic phakellistatin 13 284.253 The
macrolide spirastrellolide A was isolated as its methyl ester
285 from the Caribbean sponge Spirastrella coccinea. Unlike
many other sponge-derived antimitotic macrolides, 285 does not
effect tubulin polymerisation.254 Anasymmetric synthesis of (−)-
peloruside A, the antipode of the natural product 286 originally
isolated from the New Zealand sponge Mycale hentscheli,255
has been achieved via a Mitsunobu-type lactonisation.256 The
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synthetic antipode proved to be biologically inactive in cytotox-
icity assays, but established the absolute stereochemistry of the
natural (+)-enantiomer 286 as drawn. The relative and absolute
stereochemistries of the C23–C35 portion of reidispongiolide
A 287, isolated from the New Caledonean sponge Reidispongia
coerulea,257 have been established by synthesis of an ozonolysis
fragment of the natural product.258 The total synthesis of (+)-13-
deoxytedanolide, originally isolated from the Japanese sponge
Mycale adherens,259 has been accomplished.260 The natural
enantiomer of lasonolide A, isolated from a Caribbean Forcepia
species,261 has also been synthesised and found to be bioactive.262
The hexabromobiphenylether fromDysidea herbacea263 has been
synthesised and found to be a potent aldose reductase (ALR2)
inhibitor.264 The Micronesian sponge Cribrochalina olemda
was found to contain a new N-methyl-D-aspartate (NMDA)
receptor ligand, cribronic acid 288, which has potent convulsant
activity in mice.265 The known antioxidant amino acid L-5-
hydroxytryptophan was found to be a major constituent of
the NW Atlantic intertidal sponge Hymeniacidon heliophila and
was observed to suppress apoptosis in human lymphocytes at
concentrations similar to those found in the sponge tissue. Since
UV light induces apoptosis, it is proposed that the high concen-
trations of L-5-hydroxytryptophan act to protect this sponge
species from sunlight UV damage.266 The pyridinium alkaloid
simplakidine A 289 was isolated from the Caribbean sponge
Plakortis simplex.267 The rather remarkable tris-pyridinium
alkaloid viscosamine 290 has been isolated from the Arctic
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sponge Haliclona viscosa. The trimeric nature of this alkaloid
was deduced from a series of ions in the mass spectrum.268
Halitulin 291, isolated from a South African collection of
Haliclona tulearensis,269 has been synthesised, establishing C-
15 as (S).270 Clathryimine, originally isolated from Clathria
basilana,271 has been synthesised using palladium-catalyzed
cross-coupling reactions.272 Hachijodines F and G, isolated
originally from Xestospongia and Amphimedon species,273 have
been synthesised. The N-oxide moieties were introduced using
modified Mukiyama conditions.274 Pyrinodemin A 292, isolated
from a Okinawan collection of an Amphimedon species,275 con-
tinues to attract considerable attention from synthetic organic
chemists.231 The position of the cis double bond has been
contentious, with the originally published structure 292 being
modified to 293276 and 294277 respectively. The structure 294
has now been synthesised asymmetrically by two independent
groups establishing the absolute stereochemistry of the bicyclic
core.278,279 One group was also able to compare the spectral data
to the original spectra of the natural product and confirm the
structure as 294.278 Petrosin and petrosin A, originally isolated
from Petrosia seriata,280,281 were found to inhibit HIV-1 replica-
tion andHIV-1 reverse transcriptase.282 The total synthesis of the
(+)-antipode of nakadomarin A 295, originally isolated from an
Amphimedon species,283 has established the absolute stereochem-
istry of the (−)-natural enantiomer as (RRRR).284 Three new
manzamine alkaloids 296–298, the related harman-1-one 299,
and des-N-methylxestomanzamine A 300 were isolated from an
Indonesian sponge.285 Three b-carbolines, 3-bromofascaplysin
301, 14-bromoreticulatine 302 and 14-bromoreticulatate 303,
have been reported as metabolites of Fascaplysinopsis reticulata
from Indonesia and Fiji. 3-Bromofascaplysin was also reported
as a metabolite of the tunicate Didemnum sp.286 Three iodine-
containing indole alkaloids, plakohypaphorines A–C 304–306,
were also obtained from the same Caribbean Plakortis sim-
plex collection that yielded simplakidine (vide supra). This is
the first report of naturally occurring iodoindole alkaloids.287
Damirones A and B288 have been prepared from the corre-
spondingmakaluvamines by alkaline hydrolysis, suggesting that
the damirones may be artifacts of isolation and not naturally-
occurring compounds.289 The Indonesian sponge Biemna fortis
yielded the pyridoacridine alkaloid labuanine 307, which along
with two related synthetic pyridoacridine alkaloids and the
previously isolated biemnadin,290 were found to be inducers of
neuronal differentiation.291 Several newantimicrobial aaptamine
type alkaloids 308–312 were isolated from an Indonesian
Xestospongia species,292 while from a Japanese Neopetrosia sp.
a further tetrahydroisoquinoline alkaloid, renieramycin J 313,
was reported.293 The dark blue, cytostatic and antimicrobial
metabolite, cribrostatin 6 314, was isolated from a species of
Cribrochalina from the Maldives.294 The dictyodendrins A–
E 315–319, isolated from the Japanese sponge Dictyoden-
drilla verongiformis were found to inhibit telomerase activity.295
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Phloeodictine A1, originally isolated from a New Caledonian
sponge of the genus Phloeodictyon,296 has been synthesised.297
N,N-Dimethylnaamine D 320 and leucettamine C 321 are
reported as new, mildly antimicrobial metabolites of two Fijian
Leucetta species.298 The same research group has also isolated
three further imidazole-containing alkaloids, calcaridine A 322
spirocalcaridine A 323 and spirocalcaridine C 324, from one
of the two Leucetta collections.299 Isonaamidines A and C,
originally isolated from an Indo-Pacific Leucetta species,300 have
been synthesised.301 Sventrin, isolated from Agelas sventes,302
has been synthesised by a Red-Al reduction of an alkyne.303
An MT1-MMP inhibitor, ageladine A 325, was isolated from a
Japanese Agelas nakamuri collection.304 Oroidin-type alkaloids
with novel skeletons, the latonduines A 326 and B 327, were
obtained from an Indonesian Stylissa carteri collection.305 A
Stylissa aff.massa, obtained from Japanese waters, was found to
contain a geranylgeranyltransferase type I inhibitor, massadine
328.306 Crambescidin 826 329, isolated from a Monanchora
sp. collected in Palau, was found to be a potent inhibitor
of HIV-1 envelope-mediated fusion, along with the known
compounds crambescidin 800307 and fromiamycalin,308 while
dehydrocrambine A 330, also isolated from this sponge, was
found to be a weak inhibitor only.309 A related antibacterial
guanidine alkaloid, Sch 575948 331, was isolated from a Ptilo-
caulis spiculifer (Crambe crambe) specimen.310 Two antimitotic
guanidine/bromotyrosine alkaloids, ceratamines A 332 and B
333, were isolated from a Papua New Guinean Pseudoceratina
sp.311 An Indian collection of Psammaplysilla purpurea was
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found to contain the antibacterial bromotyrosine-derived alka-
loids purpuramine K 334 and L 335.312 Aerothionin, originally
isolated fromVerongia aerophoba,313 has been found to be active
against drug-resistant strains of Mycobacterium tuberculosis
and several other Mycobacterium sp.314 A Chinese collection
of the sponge Phakellia fusca yielded a remarkable series of
fluorinated uracil derivatives 336–340. The presence of fluorine
was confirmed by X-ray diffraction and 19F NMR studies.
This is the first report of fluorine-containing marine natural
products.315 Sponge-derived merosequiterpenoids continue to
be a fruitful area of research for both natural product and
synthetic chemists. Isoarenarol 341, isolated from a Papua New
Guinean collection of Dysidea arenaria, was found to be a po-
tent protein kinase inhibitor.316 Spongiaquinone, isolated from
Stelospongia conulata,317 has been prepared in an asymmetric
synthesis. The absolute stereochemistry was assigned based on
comparison of the optical rotation of the synthetic methyl
ether with that of the natural compound.318 A Micronesian
Aka species has yielded three new sesquiterpenoid quinols,
akaol A 342, 343, and the tentatively assigned siphonodictyol
I 344.319 Also isolated was siphonodictyal C 345, originally
isolated from Siphonodictyon coralliphagum320 and previously
described as a free phenol. However the sample isolated from
the Aka sp. had identical NMR spectra and clearly shows
the presence of SO3Na by ESIMS.319 The sulfate group is
lost in EIMS, the technique used for characterisation in the
original isolation procedure.320 Siphonodictyal C was a modest
inhibitor of complexation in the CDK4/cyclin D1 assay.320
The moderately cytotoxic neodactyloquinone 346 and the
dactylolactones A–D 347–350were obtained from anOkinawan
collection of Dactylospongia elegans.321 A Great Barrier Reef
species of Spongia yielded the sesquiterpenoid aminoquinone
cyclosmenospongine 351, which was found to be moderately
cytotoxic to murine Ehrlich carcinoma cells.322 Methanolic
extracts of an Indonesian sponge of the genus Hyrtios yielded
three new puupehenone derivatives 352–354, but which are
proposed to be artifacts of isolation from puupehenone.323 The
biosynthesis of the sesquiterpenoid dichloroimines, stylotellanes
A and B,324 was investigated. Incorporation of labelled farnesyl
isocyanide and farnesyl isothiocyanate demonstrated the role
of these compounds as intermediates in the formation of the
stylotellanes.325 10-Formamido-4-cadinene 355, isolated from
the Japanese sponge Acanthella cavernosa, was found to inhibit
the settling of the cyprid (barnacle) larvae Balanus ainphitrite.326
The Indonesian sponge Axinyssa aculeata and its nudibranch
predatorPhyllidia varicosawere both found to contain the mod-
erately antifungal 9-thiocyanatopupukeanane sesquiterpenoids
356 and 357.327 2-Thiocyanatoneopupukeanane 358, originally
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isolated from the sponge Phycopsis terpnis,328 was subsequently
revised to the endo stereochemistry on the basis of long-range
1H-1H coupling and NOE correlations.329 Both enantiomers
have been synthesised from (R)-carvone via the corresponding
alcohols330 and the stereochemistry of 358 has now been fully
established via anX-ray structure of the nitrobenzoate derivative
of the corresponding alcohol.331 A Japanese Axynissa species
yielded the mildly cytotoxic diterpene, axinyssene 359.332 An
enantioselective synthesis of (−)-nakamurol, originally isolated
from the Okinawan sponge Ageles nakamuri,333 established
the relative and absolute stereochemistries of the naturally-
occurring 360 enantiomer.334 Synthesis of the proposed structure
of aplyroseol-14 361, originally isolated from the New Zealand
spongeAplysilla rosea,335 did not yield spectra similar to those of
the natural product. The revised structure, 362, was synthesised
and found to be spectrally identical with aplyroseol-14.336 Six
cycloamphilectenes isolated from an Axinella species collected
in Vanuatu were found to be potent inhibitors of nitric oxide
production by murine macrophages.337 Only one (N-formyl-
7-amino-11-cyclocamphilectene) of the six compounds in this
study has had a structure determination published.338 The C-25
sesterterpenoids and related nor-compounds are characteristic
of sponges, especially those of Dictyoceratid origin. A cytotoxic
norsesterterpenoid, mycaleperoxide 363, was isolated from a
Mycale species collected in Thailand. The relative and absolute
stereochemistries were established by standardmethodology, in-
cluding chemical interconversions.339 Two moderately cytotoxic
norsesterterpenoids, sarcotins N 364 and O 365, along with a
sesterterpenoid 366, four pyrrolosesterterpenoids 367–370 and
ent-kurospongin 371were isolated from twoKoreanSarcotragus
species.340 The previously reported sarcotin I 372341 was found to
have the (21R) configuration.340 Three norsesterterpenoids 373–
375 and two sesterterpenoids 376 and 377, isolated from an Ok-
inawan Ircinia species, were found to be moderately cytotoxic.342
Darwinella australensis collected from NW Australia contained
sesterterpenoid sulfates 378–380 that inhibited the cell division
of sea urchin eggs, but were not cytotoxic to human leukemia
cells.343 An Ircinia species collected at -70 m by dredging in the
Gulf ofMexico contained a tricyclic sesterterpenoid, Sch 599473
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381,344 while the Antarctic sponge, Suberites caminatus yielded
the rearranged sesterterpenoid aldehyde caminatal 382.345 An
asymmetric synthesis of (−)-cacospongionolide F, isolated from
Fasciospongia cavernosa,346 confirmed the original stereochem-
ical assignments.347 The bicyclic lactone astakolactin 383 and
the pentacyclic diacetate 16-acetoxy-dihydrodeoxoscalarin 384
were obtained from specimens of Cacospongia scalaris collected
in Greece.348 A Spongia species collected in Japan yielded three
cytotoxic pentacyclic sesterterpenoids 385–387.349 Seven new
polyhydroxy sterols 388–394 were isolated from a Japanese
Acanthodendrilla species along with three known agosterols.
These were found to be proteasome inhibitors.350 Clathriol B
395, isolated from the New Zealand sponge Clathria lissosclera,
was found to inhibit the production of superoxide from human
neutrophils.351 A sterol sulfate, Sch 572423 396, along with
the previously described halistanol sulfate,352 isolated from
a Topsentia species collected in the Bahamas, were found
to bind to P2Y12 receptors.353 Another deep-water Bahaman
sponge, belonging to the family Astroscleridae, yielded the
trisulfated sterol Sch 575867 397,354 while a series of steroidal
oligoglycosides, themycalosides B–I 398–405, have been isolated
from the Cuban sponge Mycale laxissima. The mycalosides
are inhibitors of the fertilisation of sea urchin eggs.355 Four
significantly cytotoxic steroidal alkaloids, plakinamines I–K
406–408 and dihydroplakinamine K 409, were isolated from
a Philippine sponge Corticium niger.356 The halogenated and
rearranged norsteroid, nakiterpiosin 410, isolated from the
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Okinawan Terpios hoshinota, was found to be cytotoxic to
murine P388 leukemia cells.357 Hippospongic acid A, originally
isolated from a Japanese Hippospongia species,358 inhibits all
classes of vertebrate DNA polymerases and human topoiso-
merases I and II, but is inactive towards DNA polymerases
from plants, insects and prokaryotes.359 Two mildly cytotoxic
polyoxygenated triterpenes, yardenones A 411 and B 412 were
isolated from a Yemenese collection of Axinella cf. bidderi.360
8 Coelenterates
The number of new metabolites reported annually from coe-
lenterates has remained relatively constant over the 2002–
2003 period. A new sphingosine derivative 413 was reported
from a soft coral Nephthea sp. collected at the Andaman
and Nicobar Islands, Indian Ocean,361 while investigations of
Sinularia grandilobata andSinularia sp. specimens from the same
location afforded 414–416 as antimicrobial metabolites.362 The
absolute stereochemistry of the N-palmitate 417, isolated from
a Bay of Bengal collection of Nephthea sp., was deduced by
analysis of 1H-1H coupling constants of the acetonide derivative
and comparison of optical propertieswith known compounds.363
Acylspermidines 418–420, isolated fromanOkinawan collection
of Sinularia sp. soft coral,364 were all potently cytotoxic towards
A431 cells. In a separate study 419 and 420 were found to be
potent inhibitors of plant vacuolar H+-pyrophosphatase.365 The
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phenol 421 was isolated from a Taiwanese collection of Isis
hippuris,366 while investigation of a Japanese collection of the
stony coral Tubastraea sp. afforded bisindole alkaloids 422–
424.367 From Israel, eight new oxylipin derivatives were reported
from Gulf of Aqaba collections of Dendronephthya sp. (425–
428), Tubipora musica (429 and 430) and Dendrophyllia sp. (431
and 432) coelenterates.368 Stereochemical configurations were
secured by standard methods. All eight metabolites exhibited
biological activity towards bacteria, brine shrimp, sea urchin
egg development and crown gall potato tumours. Fifteen new
members of the clavulone family of prostanoids 433–447 were
reported from an Okinawan collection of Clavularia viridis.369
The absolute configurations of 433–443, 445 and 446 were
secured by analysis of CD data while those of 444 and 447 were
proposed based upon biogenetic considerations. Prostanoids
448–450, possible biosynthetic precursors to the clavulones,
were also isolated from an Okinawan collection of C. viridis.370
By utilising protease and detergent fractionation methodology,
clavulones and arachidonic acid have been located in host
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C. viridis membranes, as opposed to the closely associated
symbiont Symbiodinium sp.371 Sesquiterpenes ainigmaptilones
A 451 and B 452 were isolated from a Weddell Sea, Antarctica,
collection of Ainigmaptilon antarcticus.372 Ainigmaptilone A
demonstrated activity in a number of ecologically-relevant
assays, including antibiotic and feeding deterrence properties.
Furanosesquiterpene 453, reported from the Antarctic gor-
gonian Dasystenella acanthina, bears a trans-ring junction as
determined by NOESY NMR experiments and comparison
with related cis-fused isomers.373 Asymmetric synthesis of both
enantiomers of acetoxytubipofuran 454, originally isolated
from a Japanese collection of Tubipora musica,374 defined the
absolute stereochemistry as shown,375 while the structure of
echinofuran376 has been confirmed by racemic synthesis.377
Confertol 455 and nephalbidol 456 were isolated from the soft
corals Sinularia conferta and Nephthea albida respectively,378
while cladioxazole 457 was isolated from an Andaman Island,
Indian Ocean, collection of Cladiella sp.379 A full account of
the synthesis of the dolabellane diterpene claenone, previously
reported from Clavularia sp.,380 the first synthesis of palominol,
from Eunicea laciniata,381 and a new route to dolabellatrienone,
also from E. laciniata,381,382 have also been reported.383 Stereo-
selective synthesis of (+)-4,5-deoxyneodolabelline, a metabolite
of an Australian collection of Cespitularia sp.,384 has been
reported.385 The structure of kallosin A 458, a rearranged
pseudopterane diterpenoid isolated from a Caribbean collection
of Pseudopterogorgia kallos, was secured by spectroscopic and
X-ray analyses.386 Elisabethin A, isolated from P. elisabethae,387
has been synthesised utilising intramolecular [4 + 2] cyclisation
under biomimetic conditions.388 The first synthesis of the related
diterpene elisapterosin B and a new route to colombiasin A, also
isolated from P. elisabethae,389,390 have been achieved based on
[5+ 2] and [4+ 2] intramolecular cyclisations of a commondiene
intermediate.391 New members of the elisapterosin family, D 459
and E 460, were reported from a Caribbean collection of the
same organism.392 P. elisabethae is also a well recognised source
of anti-inflammatory diterpenes, new examples of which include
elisabethadione 461, elisabethol 462, pseudopterosins M–O
463–465 and seco-pseudopterosins E–G 466–468.393 Of the
eight diterpenes, 461, 464 and 466 were the most potent in
the mouse ear edema assay. The chemical steps involved in
the biosynthesis of the pseudopterosins in P. elisabethae have
been studied using 3H-labelled precursors,394 with a subsequent
study showing that diterpene production is occurring within
the dinoflagellate symbiont Symbiodinium sp.395 Preparation
of all four C-1 and C-7 stereoisomers of pseudopteroxazole
469, a mildly antimycobacterial diterpene isolated from P.
elisabethae,396 required a revision of assigned stereochemistry
to that shown,397 while a new bioactive congener, homopseu-
dopteroxazole 470, has been reported from the same organism
collected near SanAndre´s Island,Colombia.398 The structures of
theP. elisabethaemetabolites, elisabatins B399 andC,400 have been
confirmed by X-ray studies.401 Investigation of a Great Barrier
Reef collection of Sarcophyton cherbonnieri yielded furano-
cembranoids 471–473, while the same study402 also reported
new seco-cembranoids 474 and 475 from a Fijian collection of
Nephthea sp. in addition to the known cembrane decaryiol.403
Modest cytotoxicity towards a panel of tumour cell lines was
exhibited by 471, 473 and decaryiol while the latter was shown
to arrest the cell cycle at G2/M. Structures of sarcocrassolide
B 476404 and sarcophyocrassolide A 477,405 cytotoxic cembrane
diterpenes isolated from a Chinese collection of Sarcophyton
crassocaule, were secured by X-ray studies,406 as was that of
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11-epi-sinulariolide acetate 478,407 previously reported from
gorgonians collected from the Gulf of Elat. 11-epi-Sinulariolide
acetate was found to exhibit moderate cytotoxicity towards a
range of tumour cell lines. In addition to a number of known
metabolites, new nor-cembrane diterpenes leptocladolides A
479, B 480 and C 481 were isolated from a Taiwanese collection
of Sinularia leptoclados, while 479 and related compounds 1-
epi-leptocladolide A 482 and (7E)-leptocladolide A 483 were
isolated from an ethanolic extract of S. parva.408 Both 479
and 483 exhibited modest cytotoxicity towards two tumour
cell lines, but 482 was less active. Two known diterpenes,
sinuleptolide 484409 and norcembrenolide 485,410 inhibit LPS-
induced TNF-aproduction bymurinemacrophage-like cells in a
dose-dependent manner.411 Note that while the characterisation
data for the two diterpenes reported in the reference agree with
original and recent reports,408 the structures are represented with
incorrect relative stereochemistry at C-11. Cembranes 486–489
were isolated from an eastern Caribbean collection of Eunicea
tourniforti.409 The structure and relative stereochemistry of the
highly oxygenated diterpene providencin 490, purified from
Caribbean collections of Pseudopterogorgia kallos, was secured
by X-ray analysis.410 Mild cytotoxicity towards human tumour
cell lines was observed for 490. In addition to the known
metabolites stolonidiol 491 and stolonidiol monoacetate 492,
two new dolabellane diterpenes, clavinflols A 493 and B 494,
were isolated fromaTaiwanese collection ofClavularia inflata.411
While 491, 492 and 494 exhibited selective cytotoxicity towards
the KB cell line, 493 was selective towards the Hepa cell line.
In contrast, the acetoxy derivatives 495 and 496 were essentially
inactive in the same assays. Pachyclavulariolides M–R 497–502
were isolated from a Taiwanese collection of Pachyclavularia
violacea.412 P388 cell line growth inhibition was observed for
497. (Z)-Sarcodictyin A 503 is a potently cytotoxic diterpenoid
isolated from a Japanese collection of Bellonella albiflora.413
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The absolute stereochemistry of 503 was related to sarcodictyin
A 504 by transesterification and comparison of CD spectra.
Spectroscopic discrepancies observed for the enantioselectively
synthesised structure originally proposed for alcyonin 505,
isolated from the Okinawan soft coral Sinularia flexibilis,414 have
led to the proposal that the correct structure of the natural
product is the allylic peroxide 506.415 The structures of briarellins
E 507 and F 508, isolated from a Puerto Rican collection of
Briareum asbestinum,416 were confirmed by enantioselective total
synthesis, which also established the absolute configuration of
the diterpenes.417 In addition to a number of known compounds,
new briarellins J–P 509–515, two unnamed congeners 516 and
517 and polyanthellin A 518 were reported from a Puerto Rican
collection ofBriareum polyanthes.418 Spectroscopic evidence was
also presented for revision of the structure of briarellin A from
519419 to peroxide 520, and reformulation of the structures of
521 and 522, isolated from an Australian collection of Briareum
sp. in 1989,420 to the enantiomers of 518 and 523 respectively.
Antimalarial testing against Plasmodium falciparum indicated
511, 516 and 517 to be the most active. Two investigations of
the chemistry of Junceella juncea, one using specimens collected
from the Tuticorin coast of the Indian Ocean, yielded juncins I–
M 524–528,421 while aTaiwanese collection of the sameorganism
afforded juncin N 529.422 Additional studies of J. juncea from
Taiwan afforded juncenolides B–D 530–532423 and juncenolide
E 533,424 of which 531 exhibited mild cytotoxicity towards Hepa
and KB cell lines.423 A different diterpene structure 534, isolated
from an Indian Ocean collection of J. juncea, was also given
the trivial name juncenolide B.425 A Taiwanese collection of
Junceella fragilis yielded 9-O-deacetylumbraculolide A 535.426
The structurally related epoxides briaexcavatolides S–V 536–
539 were isolated from Taiwanese specimens of Briareum
excavatum,427 while a Taiwanese collection of J. fragilis was
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the source of junceellolide H 540.428 Briarlides A–H 541–
548, obtained from Amami Oshima, Kagoshima Prefecture
collections of Briareum sp., were evaluated for cytotoxicity
towards Vero and MDCK cell lines where modest activity was
observed for 541, 544–546, weak activity for 542, 543 and 547
while 548 was inactive.429 In addition to a number of known
metabolites, seven new briaranes, erythrolides R–U 549–552,
an erythrane, erythrolide V 553, and two aquariane-skeletoned
diterpenes, aquariolides B 554 and C 555, were reported
from a Caribbean collection of Erythropodium caribaeorum.430
Aquariolide A 556, previously isolated from aquarium-grown
specimens of E. caribaeorum,431 was also identified from the
organism collected in the wild. The relative stereochemistries of
549–555 were determined either by conversion to known related
derivatives, or by interpretation of ROESYNMRdata, while for
erythrolide S 550,Moshermethodology established the absolute
configuration of the 3-hydroxybutanoyl side chain as (3′S).
The biosynthetic relationships between a number of erythrolide
diterpenes, involving possible enzymatic-mediated di-p-methane
and vinyl-propane rearrangements were discussed. The study
also reported that the known metabolites erythrolides P432
and J433 exhibited modest cytotoxicity towards the MCF7
tumour cell line. An Okinawan collection of Xenia sp. yielded
the known metabolite xeniolide A434 as well as new xenicane
diterpenes dihydroxeniolide A 557 and isoxeniatriacetate 558.435
The absolute configuration of 557 was established (Mosher
method),while the absolute configurationof 558wasdetermined
by synthesis from the stereochemically-defined xeniolide A.436
13-Epi-9-deacetoxyxenicin 559 was isolated as a cytotoxic
component of Asterospicularia laurae collected on the Great
Barrier Reef, Australia.437 Good activity was observed for
559 against P388D1 cells, while the known metabolite 13-
epi-9-deacetylxenicin 560438 was less active. DCM or ether
solutions of 559 readily underwent autoxidation to afford the
hydroperoxide 561, while 560was found to be resistant to further
reaction. The stereochemistries of sesterterpenes cladocorans
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A 562 and B 563, isolated from Mediterranean collections of
Cladocora cespitosa,439 have been revised by total synthesis,440
while preparation and testing of related stereoisomers indicated
the series exhibits cytotoxicity towards a panel of human tumour
cell lines.441 Pregnane acetal 564 was isolated from an ethanol
extract of Subergorgia suberosa, collected off the Mandapam
coast, Indian Ocean,442 while a Taiwanese collection of Isis
hippuris afforded the polyoxygenated steroids hippuristerones
E–I 565–569.443 New gorgosterol and ergosterol derivatives 570–
574 were isolated from a Great Barrier Reef collection of Cap-
nella lacertiliensis.444 All compounds exhibited weak antifungal
activity while 573 and 574 also weakly inhibited tyrosine kinase
p56lck. The spiroketal steroid 575 was isolated from a Tuticorin
coast, Indian Ocean collection of Gorgonella umbraculum,445
while the mildly cytotoxic gibberoketosterol 576 was isolated
from a Taiwanese collection of Sinularia gibberosa.446 A South
China Sea collection of Nephthea chabroli afforded the weakly
cytotoxic sterols 577 and 578,447 and the arabinopyranosylsterol
579was isolated fromCladiella krempfi, also collected inChinese
waters.448 APETx1, a 4,552 Da 42-amino acid peptide cross-
linked by three disulfide bonds, was isolated from the sea
anemoneAnthopleura elegantissima.449 The toxin inhibitsHERG
voltage-dependent K+ channels via gating modification rather
than channel pore occlusion. Pore formation by equinatoxin II,
a protein toxin isolated from the Mediterranean sea anemone
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Actinia equina,450 has been examined using combinations of 31P
NMR, 31P MAS NMR, electron microscopy,451 FTIR452 and
toxin mutagenesis.453 The ability of surface plasmon resonance
to study membrane binding processes of pore forming toxins
has been reviewed.454
9 Bryozoans
Once again, few new compounds have been reported from
bryozoans. The structural determination of the alkaloids pte-
rocellins A 580 and B 581, isolated from the marine bryozoan
Pterocella vesiculosa collected in New Zealand, relied in part on
anX-ray diffraction study of pterocellinA 580. Both pterocellins
A and B exhibit potent antimicrobial and antitumour activity in
vitro, but only displayedmodest activity in an in vivo hollow fibre
assay.455 The b-carboline alkaloid 8-hydroxyharman 582 was
isolated from a sample of the New Zealand marine bryozoan
Cribricellina cribraria.456 A number of brominated alkaloids
and a diterpene from the North Sea bryozoan Flustra foli-
acea457,458,459,460,461 were tested against bacteria derived from ma-
rine and terrestrial environments. These compounds exhibited
significant activities against one ormoremarine bacterial strains
originally isolated from F. foliacea, but only weak activities
against the terrestrial bacteria. Dihydroflustramine C462 and
flustramine D461 exhibited N-acyl-homoserine lactone (AHL)-
antagonistic activity as determined by using the biosensors
Pseudomonas putida (pKR-C12), P. putida (pAS-C8) and E.
coli (pSB403).458 A synthesis of the cytotoxic isoquinoline
alkaloid perfragilin A, originally isolated from the bryozoan
Membranipora fragilis,463 has been reported.464
10 Molluscs
There was a slight increase in new chemistry identified from
molluscs in 2003 over that reported for the time frame of the
previous review. Irregular polypropionates placidenes C–F 583–
586 and hydroperoxide 587 were isolated from a Mediterranean
collection of Placida dendritica.465 It is likely that 587 is
derived from the known metabolite placidene A 588,466 but
whether the hydroperoxide is an artifact of isolation, or a true
natural product is unclear. The first synthesis (racemic) of the
unsaturated polypropionate photodeoxytridachione, isolated
from Placobranchus ocellatus467 and other molluscs,468 has been
reported.469 Five new azaspiracid analogues 589–593, identified
using tandem mass spectrometric techniques, were isolated
from Mytilus edulis collected off the west coast of Ireland.470
The stereochemistries of the new azaspiracid analogues are
arbitrarily shown as matching that of azaspiracid-1 594,471 the
structure and stereochemistry of which has been called in to
question by stereoselective synthetic studies.472,473 The isolation
of N-methyl-D-glutamic acid 595 from the Japanese mollusc
Scapharca broughtonii is the first report of this aminoacidderiva-
tive as a natural product.474 Monterey Bay, California, collec-
tions of Calliostoma canaliculatum afforded the disulfide-linked
dimer of 6-bromo-2-mercaptotryptamine 596 as a channel-
gating antagonist of voltage-gated potassium channels.475 6-
Bromoindirubin 597, isolated from the Mediterranean mollusc
Hexaplex trunculus, and the synthetic oxime 598 were found
to be potent inhibitors of glycogen synthase kinase-3 (GSK-
3).476 The molecular geometry of GSK-3b inhibition by 598
was determined by a co-crystallisation X-ray study. Radio- and
stable isotope incorporation studies have identifiednicotinic acid
and acetate as biosynthetic precursors of haminol-2,477 a de
novo biosynthesised metabolite of the Mediterranean mollusc
Haminoea orbignyana.478 The ability of the fungal alkaloid
gliotoxin to act as a bioaccumulated toxin of shellfish has been
examined using Mytilus edulis.479 Lamellarin D, a polycyclic
alkaloid first isolated from molluscs of the genus Lamellaria,480
has been found to be a potent inhibitor of the DNA-processing
enzyme topoisomerase I.481 Japanese and US collections of
Aplysia kurodai and A. californica were sources of the gut and
vasculature contraction inhibitory pentapeptide Pro-Arg-Gln-
Phe-Val-amide (PRQFVa).482 Precursoral peptide cDNA was
successfully cloned while PRQFVa-positive neuron distribution
inCNS and peripheral tissuewasmapped using in situ hybridisa-
tion and immunocytochemistry. Five excitatory peptides, r11a–
e 599–603 were isolated from the venom of the fish-hunting
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cone snailConus radiatus collected in the Philippines.483 Further
molecular analysis of cDNA clones defined the isolated peptides
as belonging to a new class, the I-superfamily, of conotoxins,
which contain a scaffold with four disulfide bonds (linkages not
defined). The solution conformation ofaA-conotoxinEIVA 604,
originally isolated from the Atlantic cone shell C. ermineus,484
was determined by NMR experiments and restrained molecular
dynamics calculations.485 A South China Sea collection of
Conus betulinus yielded j-conotoxin BtX 605, a 31 residue
four disulfide bond-containing K+ channel up-modulator.486 As
noted in Section 4, the revised structure487 of kahalalide F 126,
a potently cytotoxic488 depsipeptide isolated from the mollusc
Elysia rufescens and the algal dietary source Bryopsis sp.,142 has
been confirmed by careful analysis of degradation products and
chiral derivatisation.144 The mechanism of biological action of
dolastatin 11, a cytotoxic depsipeptide isolated from the sea
hare Dolabella auricularia,489 involves stabilisation of F-actin,
which has been studied using X-ray fibre diffraction of oriented
filament sols.490 Also isolated from a Japanese collection of the
sea hareD. auricularia, dolabellanin B2, a 33 amino acid residue
peptide, exhibits a broad spectrum of antimicrobial activity.491
The solution structure of attractin, a 58-residue water-borne
protein pheromone isolated fromAplysia californicahas beende-
termined byNMRmethods.492 Austrodoral 606 and austrodoric
acid 607 are new nor-sesquiterpenes isolated from the Antarctic
nudibranch Austrodoris kerguelenensis, but with 607 most likely
being an artifact of isolation.493 As noted in Section 7, the thio-
cyanatopupukeanane sesquiterpenes 356 and 357 were isolated
as an epimeric mixture from the nudibranch Phyllidia varicosa
and the nudibranch’s dietary spongeAxinyssa aculeata.327 While
both compounds were isolated from the digestive gland of the
nudibranch, epimer 357 was found to accumulate in the mantle,
suggestive of a role in chemical defense. Both compounds
exhibited mild toxicity towards brine shrimp and antimicrobial
activity with 357 being more potent. De novo biosynthesis, via
mevalonic acid, of fatty acid ester derivatives of drimane 608
and sesquiterpene 609494 in the nudibranch Doriopsilla areolata
has been determined by feeding studies utilising [1-13C]glucose,
[1,2-13C2]glucose and [1,2-13C2]acetate.495 Investigation of the
diterpenoid acylglycerol fraction of an extract of the mantle
of the Antarctic nudibranch Austrodoris kerguelenensis afforded
the acylglycerols 610 and 611.496 Also isolated were two known
1,2-diacylglyceryl esters, previously reported from the same
organism,497,498 the structures of which were corrected to 612 and
613 based upon interpretation of HMBC NMR correlations.
The de novo biosynthesis of the structurally related diterpenoid
glyceride verrucosin A499,500 by the Mediterranean nudibranch
Doris verrucosa has been investigated using both 13C- and
14C-labelled precursors.501 Four new labdane diterpenes 614–
617 were isolated from the pulmonate Trimusculus peruvianus,
collected near the Antofagasta Coast of Chile.502 Absolute
stereochemistry was secured by standard methods. Compounds
616 and 617 exhibited mild cytotoxicity towards human tumour
cell lines in vitro. The structure of aplysiallene 618, deduced for
a metabolite isolated from a Japanese collection of the sea hare
Aplysia kurodai,503 has been retracted504 and corrected to the
known bromoallene algal metabolite 619.505 The first diastere-
oselective synthesis of (−)-spongian-16-oxo-17-al, originally
isolated from the nudibranch Ceratosoma brevicaudatum,506 has
confirmed the absolute stereochemistry of the metabolite, while
synthesis of the related compound (−)-acetyldendrillol-1 620,
isolated from the nudibranch Cadlina luteomarginata,507 has led
to correction of stereochemistry at C-17.336 A further collection
of Trimusculus peruvianus, again from the Antofagasta Coast of
Chile, yielded two mildly cytotoxic polyhydroxylated steroids
621 and 622.508 The stereochemistries of 621 and 622 were
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determined by interpretation of NOESY NMR data and
comparison of chemical shifts with stereochemically-defined
related compounds.
11 Tunicates (ascidians)
The number of new secondary metabolites reported from
ascidians has remained essentially static for each of 2002 and
2003. Three new glycosphingolipid molecular species, the major
component of each being represented by 623–625, were isolated
from a Mediterranean collection of Microcosmus sulcatus.509
A full account of the synthesis of lobatamide C, a cytotoxic
macrolide isolated from Aplidium lobatum collected off the
southwestern coast of Australia,510 has been reported.511 In
addition, preliminary V-ATPase inhibition structure–activity
datawas reported indicating the importance of the salicylate ring
and enamide moieties for activity. The absolute configuration of
iejimalide B 626, a cytotoxic 24-membered macrolide isolated
from a Japanese collection of Eudistoma cf. rigida,512 has been
defined by analysis of 1H-1H and 1H-13C coupling constants,
distance geometry calculations and analysis of oxidative degra-
dation products.513 During the study the gross structure was
also corrected to that shown (13Z). Floresolides A 627, B
628 and C 629 are moderately cytotoxic cyclofarnesylated
hydroquinones isolated from an Aplidium sp. ascidian collected
at Flores Island.514 The structures and absolute configurations
of all three metabolites were secured by X-ray analysis of
629. The structures of the 3-aza-[7]-paracyclophane-containing
alkaloids haouamines A 630 and B 631, isolated from Aplidium
haouarianum collected offTarifa Island,Ca´diz,were also secured
by X-ray analysis.515 Both haouamines exhibited two sets of
NMR signals, attributed to the presence of isomers resulting
from either atropisomerism or slow pyramidal inversion of
the bridgehead amine. Of the two compounds, haouamine A
was the more potent antitumour agent. Ascidians are a well-
established source of cyclic peptides, many of which exhibit
cytotoxicity. Didmolamides A 632 and B 633 are cyclic hexapep-
tides containing all (S)-configuration amino acids isolated from
Didemnum molle collected in Madagascar.516 Both compounds
exhibited modest cytotoxicity towards a panel of tumour cell
lines. Six new congeners of the bistratamide family of cyclic
hexapeptides, E–J 634–639, were reported from a Tablas Island,
Philippines collection of Lissoclinum bistratum.517 All six com-
pounds showedweak tomoderate activity towards theHCT-116
tumour cell line. A full account of the synthesis of mollamide,
a cytotoxic cycloheptapeptide isolated from an Australian
collection of Didemnum molle,518 has been reported.519 The
solution structure of the cytotoxic cycloheptapeptide trunk-
amide A 640520,521 has been determined using 2D-NMR data
and simulated annealing methods.522 Fluorescent analogues of
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ascidian-derived depsipeptides didemnin B and tamandarin A
have been used to study short-term predator-prey relationships
between fish and marine invertebrate larvae.523 Plicatamide, a
modified octapeptide isolated from the blood of a SanDiegoBay
specimen of Styela plicata,524 and several synthetic analogues
have been found to exhibit potent antimicrobial activity, to cause
K+ efflux in Staphylococcus aureus, were potently hemolytic for
human red blood cells, and formed cation-selective channels in
model lipid bilayers.525 Structure–activity studies of halocidin,
an antimicrobial peptide (3443 Da) isolated from hemocytes
of the solitary ascidian Halocynthia aurantium,526 identified
one congener with potent antimicrobial activity, but reduced
hemolytic activity.527 Further biological investigation of the cy-
totoxic depsipeptide aplidine, isolated fromAplidium albicans,528
indicates that the compound inhibits the growth and induces
apoptosis in MOLT-4 cells through inhibition of vascular
endothelial growth factor (VEGF) secretion which blocks the
VEGF-VEGFR-1 autocrine loop necessary for growth of these
cells.529 In addition, aplidine prevents the in vitro aggregation
of the prion peptide PrP 106–126.530 EPR studies of vanadium-
binding proteins, isolated from the vanadocytes of the ascidian
Ascidia sydneiensis samea, indicate that up to 24 vanadium
ions bind per protein molecule in a mononuclear state and
that coordination is through amine nitrogens.531 The absolute
configuration of etzionin 641, an antifungal diketopiperazine
hydroxamate originally isolated from an unidentified Red Sea
ascidian,532 has been secured by synthesis of all four stereoiso-
mers of derivative 642, and direct comparison of optical rotation
values with the same natural derivative.533 An initial attempt at
expanding the structure–activity relationship of the cytotoxic
quinolizidine alkaloid clavepictine B isolated from the Bermu-
dian ascidian Clavelina picta,534 has indicated the importance
of sidechain unsaturation, and that relative stereochemistry
about the ring system does not seem to be important for
cytotoxicity.535 Two full accounts of the stereoselective synthesis
of lepadiformine, a biologically active alkaloid isolated from the
ascidians Clavelina lepadiformis and C. moluccensis,536,537 have
been reported.538,539 The structurally related ascidian alkaloids
(+)-cylindricines C–E, isolated from an Australian collection of
Clavelina cylindrica,540 were prepared using ruthenium-catalysed
hydrative diyne cyclisation methodology.541 The quaternised
indole-enamine conicamin 643 was isolated as a histamine
antagonist from a Mediterranean collection of Aplidium con-
icum.542 Cynthichlorine 644, previously known as a synthetic
product from the chlorination of methylindolyl methylester,543
was isolated from a Moroccan collection of Cynthia savignyi.544
The alkaloid exhibited antifungal activity towards two tomato
pathogenic fungi and bacteria and was also cytotoxic in the
brine shrimp lethality assay. Studies of an unidentified ascidian
collected in Madagascar have afforded the mildly cytotoxic
alkaloids barrenazine A 645 and B 646.545 The structures of the
barrenazines were secured by use of 1H-15NHMBCNMRexper-
iments, while the observance of optical rotatory properties for
645 suggested the (R*,R*) configuration. Further investigation
of the Mediterranean collection of Aplidium conicum yielded
conicaquinones A 647 and B 648, both of which exhibited
cytotoxicity towards a rat glioma cell line.546 Kottamide E 649,
the first example of a natural product bearing the amino acid 4-
amino-1,2-dithiolane-4-carboxylic acid (Adt), was isolated from
the New Zealand ascidian Pycnoclavella kottae.547 Benzotrithi-
oles related to the cytotoxic pentathiepin ascidian alkaloids
varacin548 and lissonclinotoxin A549,550 have been prepared and
optical rotatory properties and crystal structures investigated.551
Lissoclinotoxins E 650 and F 651 were isolated as mildly
cytotoxic components of a Philippine didemnid ascidian.552 The
relative orientation of the aromatic rings of 650 and 651 were
deduced, as shown, based upon molecular modeling studies.
New members of the rigidin family of pyrrolopyrimidine alka-
loids, rigidins B–D 652–654, were isolated from an Okinawan
collection of Cystodytes sp.,553 while rigidin E 655 was isolated
from a Papua New Guinea collection of a Eudistoma species.554
Rigidins B–D were mildly cytotoxic towards the L1210 murine
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leukemia cell line553 while rigidin 656555 and rigidin E were
not cytotoxic towards A431 and wild-type and p53 deficient
HCT-116 human tumour cell lines.554 Two b-carboline alkaloids,
eudistomins W 657 and X 658, were isolated from Chuuk Atoll,
Micronesia collections of a Eudistoma species.556 The absolute
stereochemistry of 657 was ascertained (Mosher method), and
658 was found to be more potent in antimicrobial assays.
ShishijimicinsA–C 659–661 are extraordinarily potent cytotoxic
enediyne antibiotics isolated from a South Japan collection of
Didemnumproliferum.557 Relative and absolute stereochemistries
were determined by standard methods and by comparison of
CD data with that reported for the calicheamicins, terrestrial
microbe-derived enediyne antibiotics. Distomadines A 662 and
B 663 are new 6-hydroxyquinoline alkaloids from the New
Zealand ascidian Pseudodistoma aureum.558 The structure of
styelsamine C, an hydroxylpyridoacridine alkaloid isolated from
the Indonesian ascidian Eusynstyela latericius,559 has been con-
firmedby synthesis.560 Asnoted in Section 7, 3-bromofascaplysin
301 was isolated from extracts of a Didemnum species ascidian
collected at Chuuk Atoll, Micronesia, as well as from Fijian
collections of Fascaplysinopsis sponges.286 The structure of
sebastianine A, a pentacyclic alkaloid isolated from a Brazilian
collection of Cystodytes dellechiajei,561 has been confirmed by
total synthesis.562 Continued study of ascididemin, isolated
from a Japanese collection of a Didemnum sp.,563 indicates that
derivatives are also active in antiparasitic assays,564 that the
antitumour activity can be varied somewhat predictably,565,566
and that a mechanism of reductive activation to form reactive
oxygen species also contributes to the cytotoxicity of the
parent alkaloid.567 The structure of bengacarboline, a cytotoxic
alkaloid isolated from a Fijian collection of a Didemnum
sp.,568 has been confirmed by total racemic synthesis.569 A
convenient solid-phase synthesis of the ascidian metabolites
lamellarin L570 and U571 has been reported.572 New improved
syntheses of (−)-diazonamide A 664 have been reported,573,574
and investigation of the mechanism of action of 664 and
analogue 665 indicate that the alkaloids are potent inhibitors
of microtubule assembly, possibly at a unique site.575 Efficient
syntheses of the naturally occurring cytotoxic ecteinascidins
ET-729, -745, -759B, -736, -637 and -594576,577,578,579,580 from the
fermentation product cyanosafracin B have been reported.581
The parent compound, ET-743, continues to progress through
clinical trials.582,583,584 Ritterazine B, a dimeric steroidal alkaloid
isolated from Ritterella tokioka,585 induces apoptosis in HL-60
cells and causes cell cycle accumulation at G2/M, but has no
caspase activation effect nor does it alter phosphorylation of bcl-
2.586 AplidiasterolsA 666 andB 667 are new cytotoxic secosterols
isolated fromaMediterranean collectionofAplidium conicum.587
The structure and absolute stereochemistry of a steroidal sperm-
activating and attracting factor 668 isolated from the ascidian
Ciona intestinalis588 has been unambiguously determined by
total synthesis.589
12 Echinoderms
A similar number of new compounds were reported from
echinoderms in 2003 comparedwith 2002. This field continues to
be dominated by glycosylated ceramides and saponins. Taurine
derivative 669 was isolated from a Gomun Island, Korea,
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collection of the starfish Certonardoa semiregularis.197 Investi-
gation of the Patagonian starfish Anasterias minuta afforded
a range of metabolites including the new glucosylceramide
anasterocerebroside A 670.590 The known ceramide 671591,592 was
also characterised for the first time. A Japanese collection of
the starfish Luidia maculata yielded four ceramide lactosides,
luidialactosides A–D 672–675.593 The position of the olefin in
the long chain base of 674 was deduced by FABMS analysis
of a dimethyl disulfide derivative. Three ganglioside molecular
species, SCG-1–3, the major species of which are represented
by 676–678, were isolated from the Japanese sea cucumber
Stichopus chloronotus.594 All three species displayed neuritogenic
activity against PC12 cells in the presence of nerve growth factor.
A structurally more complex ganglioside molecular species
SJG-2 679, isolated from a Japanese collection of Stichopus
japonicus, also exhibited neuritogenic activity.595 Brine shrimp
lethality assay-directed fractionation of the starfishCertonardoa
semiregularis, collected off Komun Island, Korea, afforded
thirteen new polyhydroxysterols. These were certonardosterols
A–M 680–692,596 as well as the known 693.597 Side chain
configurations at C-24 (for 686 and 693), C-25 (for 680) and both
C-24 and C-25 (for 688) were determined (Mosher method). All
of the sterols, with the exception of 692, exhibitedmodest in vitro
cytotoxicity towards a panel of human tumour cell lines. A range
of hemolytic steroid disulfates, including new examples 694 and
695, were reported from the starfish Pteraster pulvillus collected
by trawling in the Sea of Okhotsk in the Far East.598 Unusual
alkaloid cation and steroidal anion compounds 696–698 were
isolated from the starfish Lethasterias nanimensis chelifera
collected by trawling near the Kuril Islands in the Far East.599
Comparison of optical rotation values identified the cation as
being the (R)-isomer of salsolinol. Steroid glycosides (saponins),
commonly isolated from echinoderms, present challenges in
structural elucidation and exhibit a diverse range of biological
activities, both aspects of which have been reviewed.600,601 Four
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new saponins, certonardosides K–N 699–702, isolated from the
starfish Certonardoa semiregularis collected off Komun Island,
Korea, exhibited varied biological activity towards a range of
tumour cell lines and bacteria.602 Configuration at C-24 in 699,
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701 and 702was secured bymethanolysis and analysis ofMTPA
ester derivatives. The polyhydroxylated steroid ketone 703 and
monoglycosylated steroid 704 were reported from collections of
the Far Eastern starfishHenricia sanguinolenta andH. leviuscula
leviuscula.603 Both compounds mildly inhibited division of
fertilised sea urchin eggs. A South China Sea collection of the
sea cucumber Mensamaria intercedens yielded intercedensides
A–C 705–707, novel triterpene glycosides that exhibited in vitro
cytotoxicity towards a panel of human tumour cell lines.604
Intercedenside A also exhibited in vivo activity towards Lewis
lung and mouse S180 sarcoma tumour models. A Sea of Japan
collection of the sea cucumber Cucumaria conicospermium also
afforded triterpene glycosides, cucumariosides A2-5 708, A3-2
709, A3-3 710 and isokoreoside A 711, all of which contain
the same pentasaccharide moiety, but differ in the number
and position of the sulfate groups and the aglycone.605 Limited
quantities of two new saponins ruberoside E 712 and F 713were
isolated from specimens of the starfish Asterias rubens collected
in the Baltic Sea.606 The structures of both compounds were
secured using a cryogenic NMR probe in an LC-NMR-MS
configuration. Two mildly cytotoxic saponins, luidiaquinoside
714 and psilasteroside 715, were reported from collections of
the starfish Luidia quinaria collected at Sendai (Japan) and
Psilaster cassiope collected in the northern Gulf of Mexico
respectively.607 The pathological effects of sea urchin toxins has
been reviewed.608
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13 Miscellaneous
Three alkylpyrrole sulfamates 716–718 were isolated as fish-
feeding deterrent metabolites from the annelid Cirriformia
tentaculata, collected in Florida.609 Close to forty years after
the structure of tetrodotoxin was elucidated,610,611,612 the first
asymmetric syntheses of the alkaloid have been reported.613,614
14 Conclusion
In the early years of marine natural products research there was
less emphasis on biological testing, but increasingly there has
been a focus on the biological properties of these compounds.
In the first of the Faulkner reviews (1977),615 mention was made
of the antibiotic properties of only a handful of compounds and
referencemade to the P388 activity of someDolabella auricularia
metabolites. In this review of the literature for 2003, over 720
compounds are includedwith biological activities being reported
for 354 of these. The distribution of biological activities and
source phyla for these compounds in 2003 is shown graphically
in Figs. 1 and 2. The sponges and coelenterates continue to
dominate as source phyla of new compounds, with microor-
ganisms being the other major source. The relative incidence of
bioactivity detected was greatest from the green alga followed
by tunicates, echinoderms and sponges, but in absolute numbers
the sponges dominated. The reported biological testing has
been grouped into five categories, but is dominated by various
tests for anticancer and antimicrobial/antiinfective properties.
Fig. 1 Distribution of biologically-active and non-active marine nat-
ural products by phylum, 2003. (Non-active–compounds for which no
biological activity has been reported; Active–compounds that are active
in at least one bioassay).
Tunicates, echinoderms and sponges were prime sources for the
detection of potential anti-cancer properties. This combination
of source and biological activity is verymuch in keeping with the
data presented in the timely review on marine natural products
and related compounds in clinical and advanced clinical trials.616
A graphical representation of the tabular data presented in that
review is shown in Fig. 3. Progress towards marine anticancer
drugs dominates with the prime source phyla being sponges
followed by microorganisms, tunicates and molluscs. The other
categories where marine natural products are progressing are
in drugs for pain and asthmatic conditions where the interest
is centered on Conus toxins and analogues of sponge sterols
respectively.616
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Fig. 2 Distribution of biological activity by phylum. (AC–cancer
related assays including cytotoxicity, antimitotic, histone deacetylase,
proteasome, TNF, a range of kinases, DNA binding and matrix met-
alloproteinase; AM–antimicrobial, antiinfective, antiTb, antimalarial
assays; AO–antioxidant assays; IV–in vivo assays such as brine shrimp
and sea urchin eggs; Other–includes antiviral assays, assays based on
central nervous system responses, feeding deterrent assays, ion channel
assays, antifouling assays and assays for Fe siderophores, neuronal
differentiation, oocyte lysis, sperm attractant and UV-A activity).
Fig. 3 Numbers and distribution of marine and marine-derived
compounds in clinical and pre-clinical trials. (Data extracted from
Table 1 in reference 616) (C–anticancer drugs; AI–antiinflammatory
drugs; P–drugs for intractable pain; A–Alzheimers).
Since the discovery of the arabinose-based nucleosides by
Bergman over 50 years ago,617–619 the explosion of interest
in alternative nucleoside compositions and the subsequent
development ofAra-CandAra-Aas drugswith obvious linkages
to later antiviral drugs such as acyclovir and AZT, there has
been a tacit assumption that marine-based drugs would soon
be forthcoming. That has not yet happened, but the first truly
marine drugs should be licensed within the next two years.616
Yondelis, better known as ecteinascidin 743, is in Phase II and
III trials in Europe and the USA against soft tissue sarcoma,
while the Conus toxin known as Ziconotide or Prialt is in Phase
III clinical trials for intractable pain with plans for launching as
a new drug in 2005. Despite problems in 2003 with the European
Agency for the Evaluation of Medicinal Products, Yondelis will
probably also be launched in 2005.616
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